
via American Optometric Association
A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye. Neurofilament light chain, a protein previously detected in cerebrospinal fluid and blood that is being explored as a biomarker to detect neurodegeneration, has now been identified in the vitreous humor, or fluid within the eye. Published in Alzheimer’s Research & Therapy, these results set a foundation for future studies to investigate the potential of this biomarker to accelerate the diagnosis of Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative diseases.
Diseases such as Alzheimer’s Disease and Parkinson’s Disease are the result of nerve cells in the brain or peripheral nervous system losing function over time, eventually leading to cell death. While there are treatments available to address the physical and mental symptoms associated with these progressive diseases, there are no known cures, and early treatment can help delay the progression of these diseases once they start.
“One of the biggest priorities in Alzheimer’s disease research is to develop ways to diagnose the disease before the onset of symptoms, which would allow for early treatment that could help halt the progression of this fatal disease,” said Manju Subramanian, MD, an ophthalmologic surgeon at Boston Medical Center and the study’s first and corresponding author. Neurodegenerative diseases are currently diagnosed based on clinical presentation and diagnostic testing – once symptoms appear it means that the disease is already progressing.
Biomarkers are a major focus of neurodegenerative disease research given their promise as a way to detect the presence of a disease in earlier stages based on clues found in other parts of the body. Previous studies have established that amyloid- ? and tau proteins are biomarkers for Alzheimer’s disease, and they have been detected in cerebrospinal fluid, blood, and in fluid around the eye.
For this study, the researchers collected eye fluid samples from 77 patients who were undergoing previously scheduled eye surgery at Boston Medical Center. Sixty three percent of the subjects were male, and the average age was just over 56 years old. The results showed that all 77 patients had Neurofilament light chain in their vitreous humor, and higher levels of this biomarker were associated with higher levels of other biomarkers known to be associated with Alzheimer’s disease, including amyloid-B and tau proteins. Neurofilament light chain levels were not significantly associated with eye disease, which means that those levels appear not to be influenced by the clinical eye conditions affecting the patients.
As the number of people living longer has increased over the previous decades, particularly in the Western world, the prevalence of neurodegenerative diseases has also increased. According to the National Institutes of Health, Alzheimer’s disease and Parkinson’s disease are the two most common neurodegenerative diseases, affecting approximately 5.5 million and one million Americans, respectively.
“As an extension of the brain, the eye can provide important insight about what’s happening pathologically in the brain,” added Subramanian, also an associate professor of ophthalmology at Boston University School of Medicine. “We hope that these results will add another way to use information about what’s happening in different parts of the body to detect the presence of disease before neurodegeneration takes hold, causing irreversible damage. The earlier we can diagnose and treat these diseases, the better off our patients will be.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Diagnosis of neurodegenerative diseases
- Ask A Doctor: Can The Effects Of Alzheimer's Disease Result In Death?
Expert opinion from Himabindu Sreenivasulu MBBS · 1 years of experience · India Yes, Alzheimer's disease can eventually lead to death. Alzheimer's is a progressive neurodegenerative disease that ...
- Alzheimer's Breakthrough As Scientists Discover Ways To Reduce Symptoms
Two new studies reveal that electrical stimulation of the brain and light therapy treatment might help patients with Alzheimer's.
- Exploring HER-096: A novel approach to Parkinson’s Disease
In a recent interview with Henri Huttunen, we delved into the intricacies of their potential novel disease-modifying therapy, HER-096 ...
- Opinion: The Transformative Potential of Gene Therapy for Neurodegenerative Diseases
More and more, scientists are identifying and developing ways to treat the fundamental cause of certain neurodegenerative diseases rather than merely treating the symptoms. Take, for example, a ...
- What is motor neuron disease?
The specific symptoms depend on the type of MND ... Alzheimer’s disease, and other neurodegenerative diseases, compared with other people. Experts think that this could indicate a link with ...
Go deeper with Google Headlines on:
Diagnosis of neurodegenerative diseases
[google_news title=”” keyword=”diagnosis of neurodegenerative diseases” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Biomarker disease detectiion
- Biomarkers enable detection of rapidly aging organs & disease risk
Researchers have used a machine-learning model to analyze blood proteins to estimate the biological, as opposed to the chronological, age of bodily organs. It’s a way of predicting an apparently ...
- Biomarkers of Cardiovascular Disease
Type 0 biomarker: A marker of the natural history of a disease and correlates longitudinally with known clinical indices. Type I biomarker: A marker that captures the effects of a therapeutic ...
- Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual ...
“The presentations will show how comprehensive genomic profiling and residual disease detection using blood-based ... the feasibility of ctDNA genomic profiling for actionable biomarker detection and ...
- Biomarkers in Neurodegenerative Diseases for Early Detection, Diagnosis, Prognosis, and Prediction
Neurodegenerative diseases (NDDs) consist of a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, spinal ...
- Unlocking Early Detection: How Are Diagnostic Labs Revolutionizing Lung Cancer Testing?
Indian laboratories have matched global advances step by step and play an integral role in partnering with their patient and clinical colleagues to detect, diagnose and help treat.
Go deeper with Google Headlines on:
Biomarker disease detectiion
[google_news title=”” keyword=”biomarker disease detectiion” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]